| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5699315 | Clinical Oncology | 2010 | 8 Pages |
Abstract
CRT using capecitabine and limited field radiotherapy is a well-tolerated, relatively efficacious treatment for LAPC. The low toxicity and low regional progression rates support the use of limited field radiotherapy, allowing evaluation of this regimen with other anti-cancer agents.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A.S.N. Jackson, P. Jain, G.R. Watkins, G.A. Whitfield, M.M. Green, J. Valle, M.B. Taylor, C. Dickinson, P.M. Price, A. Saleem,